Key player · Company profile
Boston Scientific Corporation
Named as a key player in 231 of our reports, across 33 regions and countries.
Named as a key player in 231 of our reports, across 33 regions and countries.
2023–2033 CAGR · estimates
Australia 7
Brazil 7
Canada 7
China 7
Ecuador 7
Egypt 7
France 7
Germany 7
Hong Kong 7
India 7
Italy 7
Japan 7
Kenya 7
Malaysia 7
Mexico 7
New Zealand 7
Philippines 7
Russia 7
Saudi Arabia 7
Singapore 7
South Africa 7
Spain 7
Thailand 7
UAE 7
UK 7
US 7| Market | Category | World 2023 | CAGR |
|---|---|---|---|
| Defibrillator | Medical Devices | $17.7 Bn | 5.9% |
| Angiography Devices | Medical Devices | $12.5 Bn | 6.3% |
| Direct Energy Medical Devices | Medical Devices | $11 Bn | 5% |
| Disposable Surgical Devices | Medical Devices | $9 Bn | 7.3% |
| Angioplasty Balloons | Medical Devices | $4.1 Bn | 3.8% |
| 3D Laparoscopy Imaging Systems | Digital Health | $3.2 Bn | 6.7% |
| Anti-Venom | Pharmaceuticals | – | – |
Named as key players in the same markets as Boston Scientific Corporation (number of shared markets).
Medtronic6 shared markets
Stryker Corporation4 shared markets
B. Braun Melsungen AG3 shared markets
Smith & Nephew3 shared markets
Abbott Laboratories2 shared markets
AngioDynamics, Inc.2 shared markets
Biotronik SE & Co. KG2 shared markets
CONMED Corporation2 shared markets
Search all reports for Boston Scientific Corporation All companies